ArticleIn vivo (Athens, Greece)
Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice.
Diamantis I Tsilimigras et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
pooled itcites it